Halozyme Therapeutics, Inc. (HALO)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Show:
Annual
Cash Flow
All numbers in thousandsBreakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
318,802
281,594
202,129
402,710
129,085
Depreciation & amortization
84,605
84,856
49,641
2,997
3,284
Deferred income taxes
31,923
34,506
40,005
-155,434
0
Stock based compensation
38,528
36,620
24,397
20,820
17,204
Change in working capital
-30,930
-38,671
-85,951
3,738
-108,366
Accounts receivable
-1,220
-3,339
-83,941
6,755
-38,288
Inventory
-59,867
-26,884
-17,481
7,371
-31,388
Other working capital
423,572
373,277
235,300
297,983
52,950
Other non-cash items
-4,731
-4,626
6,927
22,352
13,603
Net cash provided by operating activites
431,034
388,571
240,110
299,440
55,454
Cash flows from investing activities
Investments in property, plant and equipment
-7,462
-15,294
-4,810
-1,457
-2,504
Acquisitions, net
-
0
-999,120
0
-
Purchases of investments
-381,755
-292,911
-255,208
-652,515
-226,185
Sales/Maturities of investments
269,789
211,296
746,127
247,683
305,967
Other investing activites
-
-
26,006
-
-
Net cash used for investing activites
-119,428
-96,909
-487,005
-406,289
78,354
Cash flows from financing activities
Debt repayment
0
-13,483
-447,453
-369,064
-19,560
Common stock repurchased
-252,300
-402,383
-200,002
-350,058
-150,117
Other financing activites
-
-
-76,224
-424
-
Net cash used privided by (used for) financing activities
-243,862
-407,987
362,371
77,865
-106,284
Net change in cash
67,744
-116,325
115,476
-28,984
27,524
Cash at beginning of period
96,883
234,695
119,219
148,203
120,679
Cash at end of period
164,627
118,370
234,695
119,219
148,203
Free Cash Flow
Operating Cash Flow
431,034
388,571
240,110
299,440
55,454
Capital Expenditure
-7,462
-15,294
-4,810
-1,457
-2,504
Free Cash Flow
423,572
373,277
235,300
297,983
52,950
© 2024 Yahoo. All rights reserved.